Table 2.
Association of Ebola Virus Disease (EVD) Survivorship With Neurological, Cognitive, and Psychological Findings (EVD Survivors, N = 20; Reported EVD Survivors, N = 14; Close Contacts, N = 187).
| Outcomes | Adjusted Coefficient for EVD Survivors (95% CI) | P Values | Adjusted Coefficient for Reported EVD Survivors (95% CI) | P Values |
|---|---|---|---|---|
| Abnormal neurologic symptoms | 0.62 (−0.67–1.92) | .35 | 0.51 (−0.99–2.00) | .51 |
| Abnormal neurological examination | 1.57 (−0.21–3.35) | .08 | 1.11 (−1.10–3.33) | .32 |
| MMSEa | −1.85 (−3.63–-0.07) | .04 | −2.10 (−4.05–-0.14) | .04 |
| GADS b | 3.91 (1.76–6.04) | <.01 | 5.89 (3.41–8.37) | <.01 |
| GADS: Depressive symptoms subscale | 1.80 (0.70–2.90) | <.01 | 2.77 (1.47–4.07) | <.01 |
| GADS: Anxious symptoms subscale | 1.98 (0.75–3.21) | <.01 | 3.04 (1.61–4.47) | <.01 |
Covariates used to adjust for confounding included age, sex, educational level, marital status, and being a healthcare worker. P values are described for adjusted models, and bold indicates a value <.05.
Abbreviations: CI, confidence interval; EVD, Ebola virus disease; GADS, Goldberg anxiety and depression scale; MMSE, mini-mental status exam.
aFolstein MMSE, scale 0–30.
bGADS, scale 0–18.